Could a simple blood test transform sepsis outcomes?
One of the persistent challenges in treating sepsis is the lack of timely diagnosis, as there is no singular diagnostic test that reliably detects sepsis. Current practices rely… read more.
One of the persistent challenges in treating sepsis is the lack of timely diagnosis, as there is no singular diagnostic test that reliably detects sepsis. Current practices rely… read more.
CStone Pharmaceuticals announced that the National Medical Products Administration (NMPA) of China has approved the supplemental biologics license application (sBLA) for sugemalimab (Cejemly) in combination with fluoropyrimidine- and… read more.
The winter flu season may be over in the northern hemisphere, but EU regulators are already looking ahead to the next outbreak in autumn 2024. Influenza viruses continuously… read more.
AstraZeneca’s Truqap (capivasertib) in combination with Faslodex (fulvestrant) has been approved in Japan for the treatment of adult patients with unresectable or recurrent PIK3CA, AKT1, or PTEN-altered hormone… read more.
Individuals with heart disease stand to gain the most from a low-sodium diet but, on average, consume over twice the recommended daily sodium intake, according to a study… read more.
A natural molecule present in coffee could improve muscle health and function, according to a new study. The molecule, trigonelline, also occurs in the human body, in the… read more.
Researchers from Fred Hutchinson Cancer Center, the American Cancer Society Cancer Action Network and peer institutions released new findings in the Journal of Clinical Oncology showing that when all types of cancer research studies are… read more.
Your weekly digest of the top healthcare stories, covering news published from 01/04/2024 – 05/04/2024. The Guardian Patients are dying needlessly every year due to vulnerable Britons with… read more.
UCB Canada Inc. is pleased to announce that Bimzelx (bimekizumab injection) has received authorization from Health Canada for two new indications. On February 23, 2024, BImzelx was approved… read more.
The lack of persistence in home physiotherapy exercises is a well-known problem hindering the effectiveness of treatment. It is especially evident in vestibular rehabilitation (exercises to treat dizziness… read more.
28th EAHP Congress Highlights The theme of the 28th EAHP congress was Sustainable healthcare – opportunities and strategies and several posters addressed different approaches to avoiding or minimising… read more.
Johnson & Johnson announced that the FDA has approved Edurant Ped (rilpivirine) for the treatment of HIV-1 in combination with other antiretroviral therapies (ARVs) in treatment-naïve children (with… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.